免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Xpert® Xpress CoV-2 plus (XPRS-COV2-10)

K 號:K242109 · 2025-01-15

申請人Cepheid®
決定日期2025-01-15
產品代碼QQX
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is the device name listed in this FDA 510(k) record. The listed applicant is Cepheid®. It received FDA 510(k) clearance on 2025-01-15 under 510(k) number K242109. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is a medical device that received FDA 510(k) clearance on 2025-01-15. The listed applicant is Cepheid®. The 510(k) number is K242109.

When did Xpert® Xpress CoV-2 plus (XPRS-COV2-10) receive FDA 510(k) clearance?

Xpert® Xpress CoV-2 plus (XPRS-COV2-10) received FDA 510(k) clearance on 2025-01-15, under 510(k) number K242109.

Who is the listed applicant for Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

The FDA 510(k) record lists Cepheid® as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Xpert® Xpress CoV-2 plus (XPRS-COV2-10)?

The FDA product code for Xpert® Xpress CoV-2 plus (XPRS-COV2-10) is QQX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Cepheid® 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 38 項裝置 →

相關器械(代碼:QQX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑